Delivery Order SPE2DB20D7066-SPE2DB25FC4HT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $1,839.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents no set-aside designation and is issued as a child order under a larger contract...
- The Defense Logistics Agency awarded a $1,046.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, an oral antibiotic commonly used to treat bacterial infections. This delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,555.75 to AmerisourceBergen Drug Corp for 60 capsules of Cefdinir 300 mg, a commonly prescribed oral antibiotic. The contract is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 2, 2025. No set-aside designation was used for this competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,591.67 firm fixed-price delivery order is for the supply of 4,567,792 capsules of the drug Cefdinir 300 mg. The contract has an ultimate completion date of April 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
- This federal contract award, valued at $2,221.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,942,991 units of the antibiotic medication Cefdinir 300 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite Delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 300 mg Cefdinir capsules, with a ceiling value of $1,062.45 and a completion date of July 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific program or business type. AmerisourceBergen Drug Corp holds a substantial...
- This federal contract award, valued at $1,507.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,119,982 units of Cefdinir 300 mg capsules in quantities of 60s. This is a firm fixed-price delivery order contract, with a completion date of June 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award, valued at $1,220.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,358,140 units of the medication Cefdinir 300 mg capsules, with a completion date of January 19, 2024. The contract is a Delivery Order under a Firm Fixed Price contract type. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This is a $2,066.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a prescription medication. The contract has a completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,320.61 firm fixed-price delivery order is for the supply of 4562262625 - CEFDINIR 300 MG CAPSULE 60S, with a completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4HTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) valued at $2,840.50. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award practices. The order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat bacterial infections across military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems, with delivery orders spanning multiple therapeutic domains including antibiotics, specialty medications, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/13/25 |